Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2026-03-09 @ 4:22 AM
Study NCT ID:
NCT01865812
Status:
COMPLETED
Last Update Posted:
2022-08-24
First Post:
2013-05-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
Sponsor:
Intercept Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
747-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None